Alzheimer’s disease is the most common type of dementia with over 3 million cases a year in the U.S. alone. Scientists believe this disease is not attributed to just one cause but by a combination of genetic, lifestyle and environment factors. This progressive disease destroys normal functions of nerve cells due to disruptions by plaque buildup and tangles in the brain.
Some symptoms of Alzheimer’s disease include loss of memory, inability to carry on conversation and change in other cognitive functions. As the disease progresses, it effects physical functions such as balance, swallowing and bladder control. The therapeutic benefits of cannabis have shown to enhance quality of life for patients through improved motor function and reduced agitation that may accompany other symptoms.
Right now, there is no way to avoid Alzheimer’s, but recent studies are discovering new Alzheimer’s prevention breakthroughs and easier identifier signs to lower risk.
Research continues to better understand the effects of CBD oil on the brain. Some early evidence suggests that CBD oil may reduce inflammation in the brain.
New research identifies the potential to inhibit plaque buildup in the brain with the proper use of medicinal cannabis. While there is no cure for Alzheimer’s disease, cannabinoids show neuroprotective traits against symptoms and may eliminate the destruction of cells. Scientists discovered the molecular basis of inflammation in the brain, highlighting that THC-like compounds may reduce levels of beta amyloid proteins, known for causing cell death in neurodegenerative disease. (Alzheimers.net)
Aricept and Cognex are two drugs currently being used to prevent plaque formation. However, when tested against the efficacy of medical cannabis, Aricept blocked plaque formation only 22% as well as cannabis and Cognex blocked plaque formation only 7% as well as cannabis. (WebMD) Therefore, there are no current medications that have significant impact on inhibiting cell death associated with such diseases. However, studies show that activating cannabinoid receptors may prevent the accumulation of amyloid-like proteins which are common for causing cell death.
In conclusion, premium cannabinoids may help prevent the buildup of toxic proteins in the brain, lessen inflammation associated with tangles and prevent cell death while also stimulating growth of neural tissue.
Therapeutic statements regarding product benefits have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. *All products contain <0.3% THC. You must be 21 to buy from www.cannaisseurbrands.com